US Stocks
/
Context Therapeutics Inc. Share Price
Context Therapeutics Inc. Share Price

Context Therapeutics Inc. Share Price

NASDAQ: CNTX | Micro Cap
$0.30
-$0.02 (-6.24%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Context Therapeutics Inc. Stock Performance

Open
$0.31
Prev. Close
$0.32
Circuit Range
N/A
Day Range
$0.30 - $0.31
Year Range
$0.30 - $3.60
Volume
13,564
Average Traded
$0.31

Context Therapeutics Inc. Share Price Today

As of 9 October 2026, Context Therapeutics Inc.'s share price is $0.30. The stock opened at $0.31, compared to its previous close of $0.32. During today's trading session, Context Therapeutics Inc.'s share price traded between $0.30 and $0.31, with an average price of $0.31. Over the past 52 weeks, the stock has recorded a high of $3.60 and a low of $0.30. In terms of performance, Context Therapeutics Inc.'s share price has declined by 87.45% over the last six months and is down 72.70% on a year-on-year basis.

Context Therapeutics Inc. Share Price Chart

$0.30$0.31
L
Show Current Price
H

Context Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$28.19M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.50
Revenue (TTM)
$0.00
Return On Equity (TTM)
-120.40%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-50.26%

Context Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$9.69-$13.03-$8.68-$14.56
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-34.47%33.38%-67.74%

Context Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$14.84-$23.96-$26.73-$36.12
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-61.46%-11.56%-35.13%

About Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Context Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.31
$0.30
-1.00%
Sep 2026
$0.39
$0.30
-27.54%
Aug 2026
$0.61
$0.41
-30.65%
Jul 2026
$0.57
$0.60
+8.55%
Jun 2026
$2.83
$0.55
-80.77%
May 2026
$2.32
$2.86
+21.19%
Apr 2026
$2.71
$2.36
-10.27%
Mar 2026
$2.14
$2.63
+16.37%
Feb 2026
$2.68
$2.26
-13.90%
Jan 2026
$1.47
$2.63
+79.79%
Dec 2025
$1.09
$1.46
+30.36%
Nov 2025
$1.07
$1.12
+3.23%

CNTX Share Price FAQs

What is Context Therapeutics Inc. share price today?

chevron-up
Context Therapeutics Inc. share price today is $0.30 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Context Therapeutics Inc. stock?

chevron-up
The 52 week high of Context Therapeutics Inc. stock is $3.60, while the 52 week low is $0.30 as of 9 Oct '26.

What is CNTX's market capitalisation today?

chevron-up
CNTX market capitalisation is $28.19M as of October 9, 2026, at 1:38 pm IST.

What is CNTX's net income for the last quarter?

chevron-up
CNTX's net income for the last quarter is -14.56B USD.

What is the 5 year returns of CNTX?

chevron-up
The 5 year returns of CNTX is -94.89% as on 9 Oct '26.

What is the high & low stock price of CNTX today?

chevron-up
CNTX stock price hit a high of $0.31 and low of $0.30 as of 9 Oct '26.

Can I buy CNTX shares in India?

chevron-up
Yes. You can buy CNTX in India by opening an international trading account.